Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rapport Therapeutics Inc | Mr. Troy A. Ignelzi | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 26.10 per share. | 21 Oct 2026 | 5,500 | 15,500 | - | 26.1 | 143,550 | - |
| Pinterest Inc (Class A) | Mr. Gokul Rajaram | Director | Sale of securities on an exchange or to another person at price $ 22.84 per share. | 21 Oct 2026 | 1,050 | 35,146 (0%) | 0% | 22.8 | 23,982 | - |
| Xylem | Ms. Meredith Emmerich | EVP & President, MCS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.35 per share. | 21 Oct 2026 | 837 | 4,610 (0%) | 0% | 106.4 | 89,015 | - |
| American International | Mr. Keith Walsh | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.75 per share. | 21 Oct 2026 | 688 | 44,274 (0%) | 0% | 81.8 | 56,244 | - |
| MeiraGTx Holdings PLC | Mr. Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 9.95 per share. | 20 Oct 2026 | 56,000 | 852,530 (2%) | 0% | 10.0 | 557,200 | - |
| Pinterest Inc (Class A) | Mr. Benjamin Silbermann | Director, Ten Percent Owner | 20 Oct 2026 | 46,875 | 46,875 (0%) | 0% | 0 | - | ||
| Pinterest Inc (Class A) | Mr. Benjamin Silbermann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.56 per share. | 20 Oct 2026 | 46,875 | 0 (0%) | 0% | 22.6 | 1,057,481 | - |
| Pinterest Inc (Class A) | Mr. Benjamin Silbermann | Director, Ten Percent Owner | 20 Oct 2026 | 46,875 | 46,875 (0%) | 0% | 0 | - | ||
| Pinterest Inc (Class A) | Mr. Benjamin Silbermann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.94 per share. | 20 Oct 2026 | 46,875 | 46,875 (0%) | 0% | 22.9 | 1,075,350 | - |
| Clover Health Investments Corp (Class A) | Ms. Karen M. Soares | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.66 per share. | 20 Oct 2026 | 19,275 | 1,573,423 | - | 4.7 | 89,822 | - |
| Aehr Test Systems | Mr. Rhea J. Posedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.77 per share. | 20 Oct 2026 | 18,000 | 65,156 (0%) | 0% | 1.8 | 31,860 | - |
| FB Fin Corp | Mr. Orrin Henry Ingram II | Director | Purchase of securities on an exchange or from another person at price $ 52.68 per share. | 20 Oct 2026 | 15,591 | 110,901 (0%) | 0% | 52.7 | 821,334 | - |
| ORIC Pharma Inc | Mr. Dominic G. Piscitelli | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.36 per share. | 20 Oct 2026 | 14,000 | 83,828 | - | 4.4 | 61,040 | - |
| ORIC Pharma Inc | Mr. Dominic G. Piscitelli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.53 per share. | 20 Oct 2026 | 14,000 | 69,828 | - | 13.5 | 189,391 | - |
| FB Fin Corp | Mr. Orrin Henry Ingram II | Director | Purchase of securities on an exchange or from another person at price $ 53.11 per share. | 20 Oct 2026 | 13,490 | 124,391 (0%) | 0% | 53.1 | 716,454 | - |
| Dynex Cap Inc | Ms. Smriti Laxman Popenoe | Director, Co-CEO and President | Purchase of securities on an exchange or from another person at price $ 10.62 per share. | 20 Oct 2026 | 10,000 | 541,098 (2%) | 0% | 10.6 | 106,200 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 20 Oct 2026 | 9,500 | 333,943 (0%) | 0% | 117.8 | 1,118,720 | - |
| Dynex Cap Inc | Mr. Byron L. Boston | Director, Co-CEO & Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 10.89 per share. | 20 Oct 2026 | 9,180 | 892,747 (3%) | 0% | 10.9 | 99,970 | - |
| Oruka Therapeutics Inc | Mr. Paul T. Quinlan PhD | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 20 Oct 2026 | 9,000 | 38,995 | - | 7.8 | 70,200 | - |
| HubSpot Inc | Mr. Brian Halligan | Director | Sale of securities on an exchange or to another person at price $ 239.57 per share. | 20 Oct 2026 | 8,500 | 59,500 (0%) | 0% | 239.6 | 2,036,345 | - |
| ZipRecruiter Inc (Class A) | Ms. Amy Garefis | EVP, Chief People Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 20 Oct 2026 | 7,879 | 202,724 | - | 4.6 | 35,950 | - |
| Guidewire Software Inc | Mr. John Mullen | President | Sale of securities on an exchange or to another person at price $ 185.00 per share. | 20 Oct 2026 | 5,400 | 178,247 (0%) | 0% | 185 | 999,000 | - |
| Republic Bancorp Inc KY | Mr. Anthony T. Powell | EVP, CHIEF LENDING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.74 per share. | 20 Oct 2026 | 5,376 | 30,339 (0%) | 0% | 42.7 | 229,770 | - |
| Synaptics Inc | Mr. Rahul G. Patel | Director, See remarks below | Sale of securities on an exchange or to another person at price $ 117.55 per share. | 20 Oct 2026 | 4,302 | 177,236 (0%) | 0% | 117.5 | 505,700 | - |
| Moog Inc (Class A) | Mr. Donald R. Fishback | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Oct 2026 | 4,200 | 3,802 (0%) | 0% | 0 | - | |
| Moog Inc (Class A) | Mr. Donald R. Fishback | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Oct 2026 | 4,200 | 4,200 (0%) | 0% | 0 | - | |
| Oruka Therapeutics Inc | Mr. Paul T. Quinlan PhD | General Counsel | Sale of securities on an exchange or to another person at price $ 78.79 per share. | 20 Oct 2026 | 4,100 | 32,995 | - | 78.8 | 323,037 | - |
| Interface Inc | Mr. Daniel T. Hendrix | Director | Sale of securities on an exchange or to another person at price $ 35.39 per share. | 20 Oct 2026 | 4,000 | 80,147 (0%) | 0% | 35.4 | 141,560 | - |
| Republic Bancorp Inc KY | Mr. Anthony T. Powell | EVP, CHIEF LENDING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.96 per share. | 20 Oct 2026 | 3,796 | 26,543 (0%) | 0% | 92.0 | 349,080 | - |
| Cytokinetics Inc | Dr. Fady Ibraham Malik, M.D.,PhD | EVP Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 20 Oct 2026 | 3,500 | 157,402 (0%) | 0% | 7.8 | 27,300 | - |
| Cytokinetics Inc | Dr. Fady Ibraham Malik, M.D.,PhD | EVP Research & Development | Sale of securities on an exchange or to another person at price $ 64.01 per share. | 20 Oct 2026 | 3,500 | 153,902 (0%) | 0% | 64.0 | 224,035 | - |
| Oruka Therapeutics Inc | Mr. Paul T. Quinlan PhD | General Counsel | Sale of securities on an exchange or to another person at price $ 79.49 per share. | 20 Oct 2026 | 3,000 | 29,995 | - | 79.5 | 238,474 | - |
| VeriSign | Mr. D. James Bidzos | Director, Exec. Chairman, Pres, & CEO | Sale of securities on an exchange or to another person at price $ 306.54 per share. | 20 Oct 2026 | 2,300 | 372,227 (0%) | 0% | 306.5 | 705,033 | - |
| Tejon Ranch Co. | Tisch Daniel R | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 16.22 per share. | 20 Oct 2026 | 2,023 | 91,784 (0%) | 0% | 16.2 | 32,813 | - |
| Dynex Cap Inc | Ms. Smriti Laxman Popenoe | Director, Co-CEO and President | Purchase of securities on an exchange or from another person at price $ 25.18 per share. | 20 Oct 2026 | 2,000 | 2,000 | - | 25.2 | 50,360 | - |
| Tejon Ranch Co. | Mr. Eric H. Speron | Director | Grant, award, or other acquisition of securities at price $ 16.22 per share. | 20 Oct 2026 | 1,791 | 9,601 (0%) | 0% | 16.2 | 29,050 | - |
| Tejon Ranch Co. | Mr. Jeffrey J. McCall | Director | Grant, award, or other acquisition of securities at price $ 16.22 per share. | 20 Oct 2026 | 1,791 | 13,089 (0%) | 0% | 16.2 | 29,050 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 551.85 per share. | 20 Oct 2026 | 1,560 | 329,023 (0%) | 0% | 551.8 | 860,883 | - |
| Analog Devices | Mr. Richard C. Puccio, Jr | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 389.46 per share. | 20 Oct 2026 | 1,500 | 48,177 (0%) | 0% | 389.5 | 584,190 | - |
| Tejon Ranch Co. | Mr. Steven A. Betts | Director | Grant, award, or other acquisition of securities at price $ 16.22 per share. | 20 Oct 2026 | 1,483 | 53,501 (0%) | 0% | 16.2 | 24,054 | - |
| Tejon Ranch Co. | Mr. Norman J. Metcalfe | Director | Grant, award, or other acquisition of securities at price $ 16.22 per share. | 20 Oct 2026 | 1,406 | 93,530 (0%) | 0% | 16.2 | 22,805 | - |
| York Water Co. | Mr. David M. Velazquez | Director | Purchase of securities on an exchange or from another person at price $ 31.08 per share. | 20 Oct 2026 | 1,287 | 1,287 (0%) | 0% | 31.1 | 40,000 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 553.97 per share. | 20 Oct 2026 | 1,260 | 327,523 (0%) | 0% | 554.0 | 697,996 | - |
| Tejon Ranch Co. | Mr. Anthony L. Leggio | Director | Grant, award, or other acquisition of securities at price $ 16.22 per share. | 20 Oct 2026 | 1,252 | 59,770 (0%) | 0% | 16.2 | 20,307 | - |
| Choice Hotels Intl Inc | Mr. Dominic E. Dragisich | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 112.00 per share. | 20 Oct 2026 | 1,227 | 90,055 (0%) | 0% | 112 | 137,424 | - |
| Impinj Inc | Mr. Arthur L. Valdez, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2026 | 1,220 | 1,220 (0%) | 0% | 0 | - | |
| Cirrus Logic Inc | Mr. Jeffrey W. Baumgartner | EVP, R&D | Sale of securities on an exchange or to another person at price $ 107.75 per share. | 20 Oct 2026 | 1,166 | 11,741 (0%) | 0% | 107.8 | 125,637 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 551.03 per share. | 20 Oct 2026 | 1,134 | 330,583 (0%) | 0% | 551.0 | 624,870 | - |
| Verizon Communincations | Mr. Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 44.48 per share. | 20 Oct 2026 | 1,100 | 99,966 (0%) | 0% | 44.5 | 48,928 | - |
| Tejon Ranch Co. | Mr. Andrew Dakos | Director | Grant, award, or other acquisition of securities at price $ 16.22 per share. | 20 Oct 2026 | 1,021 | 37,388 (0%) | 0% | 16.2 | 16,561 | - |
| Tejon Ranch Co. | Ms. Denise Gammon | Director | Grant, award, or other acquisition of securities at price $ 16.22 per share. | 20 Oct 2026 | 1,021 | 7,498 (0%) | 0% | 16.2 | 16,561 | - |
| Tejon Ranch Co. | Mr. Gregory S. Bielli | Director | Grant, award, or other acquisition of securities at price $ 16.22 per share. | 20 Oct 2026 | 1,021 | 450,357 (1%) | 0% | 16.2 | 16,561 | - |
| Dynex Cap Inc | Mr. Michael A. Sartori | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.70 per share. | 20 Oct 2026 | 1,000 | 36,579 (0%) | 0% | 10.7 | 10,700 | - |
| Oruka Therapeutics Inc | Mr. Paul T. Quinlan PhD | General Counsel | Sale of securities on an exchange or to another person at price $ 77.20 per share. | 20 Oct 2026 | 1,000 | 37,095 | - | 77.2 | 77,205 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 548.95 per share. | 20 Oct 2026 | 948 | 332,303 (0%) | 0% | 548.9 | 520,400 | - |
| QUALCOMM | Mr. Akash J. Palkhiwala | EVP, CFO & COO | Sale of securities on an exchange or to another person at price $ 175.89 per share. | 20 Oct 2026 | 940 | 21,105 (0%) | 0% | 175.9 | 165,336 | - |
| TD Synnex Corp | Ms. Reyna Thompson | President, North America | Sale of securities on an exchange or to another person at price $ 248.53 per share. | 20 Oct 2026 | 814 | 14,657 (0%) | 0% | 248.5 | 202,303 | - |
| QUALCOMM | Mr. Akash J. Palkhiwala | EVP, CFO & COO | Sale of securities on an exchange or to another person at price $ 174.90 per share. | 20 Oct 2026 | 738 | 22,045 (0%) | 0% | 174.9 | 129,074 | - |
| American Public Education Inc | Mr. Edward H. Codispoti | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.56 per share. | 20 Oct 2026 | 689 | 7,788 (0%) | 0% | 48.6 | 33,458 | - |
| TD Synnex Corp | Ms. Reyna Thompson | President, North America | Sale of securities on an exchange or to another person at price $ 247.80 per share. | 20 Oct 2026 | 619 | 15,471 (0%) | 0% | 247.8 | 153,388 | - |
| TD Synnex Corp | Ms. Reyna Thompson | President, North America | Sale of securities on an exchange or to another person at price $ 249.47 per share. | 20 Oct 2026 | 600 | 14,057 (0%) | 0% | 249.5 | 149,682 | - |
| Monopar Therapeutics Inc | Dr. Chandler D. Robinson, M. Sc.,M.B.A.,M.D. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.59 per share. | 20 Oct 2026 | 597 | 104,127 (0%) | 0% | 92.6 | 55,276 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 550.02 per share. | 20 Oct 2026 | 586 | 331,717 (0%) | 0% | 550.0 | 322,311 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 547.79 per share. | 20 Oct 2026 | 575 | 333,251 (0%) | 0% | 547.8 | 314,977 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 558.72 per share. | 20 Oct 2026 | 520 | 326,083 (0%) | 0% | 558.7 | 290,537 | - |
| Oruka Therapeutics Inc | Mr. Paul T. Quinlan PhD | General Counsel | Sale of securities on an exchange or to another person at price $ 76.12 per share. | 20 Oct 2026 | 500 | 38,095 | - | 76.1 | 38,059 | - |
| Northern Trust | Ms. Rima Qureshi, B.Com,M.B.A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2026 | 495 | 495 (0%) | 0% | 0 | - | |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 562.78 per share. | 20 Oct 2026 | 464 | 324,664 (0%) | 0% | 562.8 | 261,130 | - |
| Qualys Inc | Mr. Bruce K. Posey | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 190.49 per share. | 20 Oct 2026 | 449 | 57,869 (0%) | 0% | 190.5 | 85,529 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 556.06 per share. | 20 Oct 2026 | 440 | 326,923 (0%) | 0% | 556.1 | 244,668 | - |
| Oruka Therapeutics Inc | Mr. Paul T. Quinlan PhD | General Counsel | Sale of securities on an exchange or to another person at price $ 74.90 per share. | 20 Oct 2026 | 400 | 38,595 | - | 74.9 | 29,960 | - |
| VeriSign | Mr. D. James Bidzos | Director, Exec. Chairman, Pres, & CEO | Sale of securities on an exchange or to another person at price $ 304.32 per share. | 20 Oct 2026 | 400 | 374,727 (0%) | 0% | 304.3 | 121,729 | - |
| VeriSign | Mr. D. James Bidzos | Director, Exec. Chairman, Pres, & CEO | Sale of securities on an exchange or to another person at price $ 307.41 per share. | 20 Oct 2026 | 400 | 371,827 (0%) | 0% | 307.4 | 122,965 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 561.84 per share. | 20 Oct 2026 | 360 | 325,128 (0%) | 0% | 561.8 | 202,264 | - |
| CVB Fin Corp | Ms. Sheryl P. Laygo | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.16 per share. | 20 Oct 2026 | 359 | 13,793 (0%) | 0% | 22.2 | 7,955 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 557.12 per share. | 20 Oct 2026 | 320 | 326,603 (0%) | 0% | 557.1 | 178,280 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 560.67 per share. | 20 Oct 2026 | 315 | 325,488 (0%) | 0% | 560.7 | 176,612 | - |
| QUALCOMM | Mr. Akash J. Palkhiwala | EVP, CFO & COO | Sale of securities on an exchange or to another person at price $ 176.58 per share. | 20 Oct 2026 | 306 | 20,799 (0%) | 0% | 176.6 | 54,033 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 559.70 per share. | 20 Oct 2026 | 280 | 325,803 (0%) | 0% | 559.7 | 156,717 | - |
| Qualys Inc | Mr. Bruce K. Posey | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 189.52 per share. | 20 Oct 2026 | 244 | 58,318 (0%) | 0% | 189.5 | 46,242 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 553.14 per share. | 20 Oct 2026 | 240 | 328,783 (0%) | 0% | 553.1 | 132,754 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 563.57 per share. | 20 Oct 2026 | 221 | 324,443 (0%) | 0% | 563.6 | 124,548 | - |
| TD Synnex Corp | Ms. Reyna Thompson | President, North America | Sale of securities on an exchange or to another person at price $ 244.67 per share. | 20 Oct 2026 | 200 | 16,090 (0%) | 0% | 244.7 | 48,934 | - |
| VeriSign | Mr. D. James Bidzos | Director, Exec. Chairman, Pres, & CEO | Sale of securities on an exchange or to another person at price $ 305.24 per share. | 20 Oct 2026 | 200 | 374,527 (0%) | 0% | 305.2 | 61,048 | - |
| QUALCOMM | Mr. Akash J. Palkhiwala | EVP, CFO & COO | Sale of securities on an exchange or to another person at price $ 172.84 per share. | 20 Oct 2026 | 196 | 22,927 (0%) | 0% | 172.8 | 33,877 | - |
| QUALCOMM | Mr. Akash J. Palkhiwala | EVP, CFO & COO | Sale of securities on an exchange or to another person at price $ 171.89 per share. | 20 Oct 2026 | 176 | 23,123 (0%) | 0% | 171.9 | 30,252 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 555.09 per share. | 20 Oct 2026 | 160 | 327,363 (0%) | 0% | 555.1 | 88,814 | - |
| QUALCOMM | Mr. Akash J. Palkhiwala | EVP, CFO & COO | Sale of securities on an exchange or to another person at price $ 174.13 per share. | 20 Oct 2026 | 144 | 22,783 (0%) | 0% | 174.1 | 25,075 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 546.85 per share. | 20 Oct 2026 | 117 | 333,826 (0%) | 0% | 546.8 | 63,981 | - |
| TD Synnex Corp | Ms. Reyna Thompson | President, North America | Sale of securities on an exchange or to another person at price $ 250.65 per share. | 20 Oct 2026 | 100 | 13,957 (0%) | 0% | 250.7 | 25,065 | - |
| TD Synnex Corp | Ms. Reyna Thompson | President, North America | Sale of securities on an exchange or to another person at price $ 251.11 per share. | 20 Oct 2026 | 100 | 13,857 (0%) | 0% | 251.1 | 25,111 | - |
| Qualys Inc | Mr. Bruce K. Posey | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 184.33 per share. | 20 Oct 2026 | 84 | 58,604 (0%) | 0% | 184.3 | 15,484 | - |
| Qualys Inc | Mr. Bruce K. Posey | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 191.26 per share. | 20 Oct 2026 | 62 | 57,807 (0%) | 0% | 191.3 | 11,858 | - |
| Qualys Inc | Mr. Bruce K. Posey | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 187.26 per share. | 20 Oct 2026 | 35 | 58,562 (0%) | 0% | 187.3 | 6,554 | - |
| York Water Co. | Mr. Douglas S. Brossman | Director | Purchase of securities on an exchange or from another person at price $ 31.25 per share. | 20 Oct 2026 | 32 | 550 (0%) | 0% | 31.3 | 1,000 | - |
| Qualys Inc | Mr. Bruce K. Posey | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 185.29 per share. | 20 Oct 2026 | 7 | 58,597 (0%) | 0% | 185.3 | 1,297 | - |
| Innventure Inc | Mr. Eric Stober | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 1,818,182 | 1,818,182 | - | 0 | - | |
| Cars.com | Mr. Trent Ziegler | CFO - Designate | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 332,069 | 332,069 (0%) | 0% | 0 | - | |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.88 per share. | 19 Oct 2026 | 300,000 | 319,024 | - | 8.9 | 2,664,000 | - |
| CarGurus Inc (Class A) | Mr. Matthew Mandel | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 175,083 | 175,083 (0%) | 0% | 0 | - | |
| Forbright Inc Ordinary | Mr. Lewis A. Sachs | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Oct 2026 | 148,256 | 7,596,495 | - | - | - | |
| Forbright Inc Ordinary | Mr. Lewis A. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 148,256 | 3,326,507 | - | - | - | |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Purchase of securities on an exchange or from another person at price $ 12.25 per share. | 19 Oct 2026 | 114,864 | 2,720,423 | - | 12.3 | 1,407,601 | - |
| Venture Global Inc (Class A) | Mr. Jonathan W. Thayer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 19 Oct 2026 | 111,111 | 111,111 | - | 1.2 | 128,889 | - |
| Venture Global Inc (Class A) | Mr. Jonathan W. Thayer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.68 per share. | 19 Oct 2026 | 111,111 | 0 | - | 12.7 | 1,408,576 | - |
| Venture Global Inc (Class A) | Mr. Jonathan W. Thayer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 19 Oct 2026 | 111,111 | 111,111 | - | 1.2 | 128,889 | - |
| Venture Global Inc (Class A) | Mr. Jonathan W. Thayer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 19 Oct 2026 | 111,111 | 0 | - | 12.7 | 1,411,243 | - |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Purchase of securities on an exchange or from another person at price $ 12.43 per share. | 19 Oct 2026 | 92,029 | 2,605,559 | - | 12.4 | 1,143,957 | - |
| Coty Inc (Class A) | Ms. Kristin Blazewicz | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2026 | 86,487 | 1,055,701 (0%) | 0% | - | - | |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 317.36 per share. | 19 Oct 2026 | 82,420 | 79,142 | - | 317.4 | 26,156,811 | - |
| Gitlab Inc (Class A) | Mr. Sytse Sijbrandij | Director | Sale of securities on an exchange or to another person at price $ 53.13 per share. | 19 Oct 2026 | 73,459 | 12,712,392 | - | 53.1 | 3,902,877 | - |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 316.32 per share. | 19 Oct 2026 | 68,376 | 161,562 | - | 316.3 | 21,628,970 | - |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Purchase of securities on an exchange or from another person at price $ 12.27 per share. | 19 Oct 2026 | 64,662 | 2,513,530 | - | 12.3 | 793,448 | - |
| Coty Inc (Class A) | Ms. Anna von Bayern | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2026 | 61,050 | 1,608,299 (0%) | 0% | - | - | |
| Gitlab Inc (Class A) | Mr. Sytse Sijbrandij | Director | Sale of securities on an exchange or to another person at price $ 53.52 per share. | 19 Oct 2026 | 42,741 | 12,669,651 | - | 53.5 | 2,287,498 | - |
| Coty Inc (Class A) | Ms. Kristin Blazewicz | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Oct 2026 | 41,419 | 1,014,282 (0%) | 0% | - | - | |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 315.34 per share. | 19 Oct 2026 | 40,896 | 229,938 | - | 315.3 | 12,896,145 | - |
| Chevron | Mr. R Hewitt Pate | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.69 per share. | 19 Oct 2026 | 40,700 | 49,491 (0%) | 0% | 132.7 | 5,400,483 | - |
| Chevron | Mr. R Hewitt Pate | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 226.65 per share. | 19 Oct 2026 | 40,700 | 8,791 (0%) | 0% | 226.7 | 9,224,777 | - |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 318.26 per share. | 19 Oct 2026 | 39,298 | 39,844 | - | 318.3 | 12,506,903 | - |
| PACS Grp Inc | Mr. Jason Murray | Director, Co-Founder, CEO & Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.65 per share. | 19 Oct 2026 | 37,477 | 54,277,423 | - | 47.7 | 1,785,820 | - |
| Franklin Resources Inc | Ms. Jennifer M. Johnson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2026 | 32,625 | 3,753,930 (0%) | 0% | - | - | |
| Franklin Resources Inc | Ms. Jennifer M. Johnson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2026 | 32,625 | 638,554 (0%) | 0% | - | - | |
| Blend Labs Inc (Class A) | Mr. Nima Ghamsari | Director, HEAD OF BLEND | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 19 Oct 2026 | 27,775 | 7,750,693 | - | 0.9 | 25,664 | - |
| Coty Inc (Class A) | Ms. Ayesha Zafar | SVP Group Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2026 | 27,028 | 201,305 (0%) | 0% | - | - | |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 19 Oct 2026 | 23,327 | 847,213 | - | 5.3 | 124,799 | - |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.29 per share. | 19 Oct 2026 | 22,803 | 824,206 | - | 47.3 | 1,078,265 | - |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 314.46 per share. | 19 Oct 2026 | 22,761 | 270,834 | - | 314.5 | 7,157,379 | - |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.84 per share. | 19 Oct 2026 | 22,332 | 824,881 | - | 47.8 | 1,068,383 | - |
| American Electric Power | Mr. Douglas A. Cannon | President AEP Transmission | Grant, award, or other acquisition of securities at price $ 124.72 per share. | 19 Oct 2026 | 20,044 | 46,007 | - | 124.7 | 2,499,888 | - |
| American Electric Power | Mr. Robert B. Berntsen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 124.72 per share. | 19 Oct 2026 | 20,044 | 40,450 | - | 124.7 | 2,499,888 | - |
| Zscaler Inc | Mr. Kevin Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 19,859 | 62,627 (0%) | 0% | 0 | - | |
| Zscaler Inc | Mr. Adam Geller | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 19,859 | 58,167 (0%) | 0% | 0 | - | |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 19 Oct 2026 | 17,857 | 841,743 | - | 5.1 | 90,178 | - |
| Marathon Digital Holdings Inc | Mr. Salman H. Khan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.88 per share. | 19 Oct 2026 | 16,000 | 535,681 (6%) | 0% | 7.9 | 126,080 | - |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 319.17 per share. | 19 Oct 2026 | 14,510 | 25,334 | - | 319.2 | 4,631,186 | - |
| Zscaler Inc | Mr. Robert S. Schlossman | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 14,185 | 75,710 (0%) | 0% | 0 | - | |
| Heron Therapeutics Inc | Mr. Craig A. Collard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2026 | 13,797 | 870,289 (0%) | 0% | - | - | |
| Disc Medicine Inc | Dr. Kevin Bitterman, PhD | Director | Sale of securities on an exchange or to another person at price $ 80.23 per share. | 19 Oct 2026 | 13,783 | 296,277 | - | 80.2 | 1,105,810 | - |
| OBOOK Holdings Inc Ordinary | Mr. Chun-Kai Wang | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.27 per share. | 19 Oct 2026 | 12,192 | 3,137,000 | - | 4.3 | 52,037 | - |
| MediaAlpha Inc (Class A) | Mr. Keith Cramer | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 11.39 per share. | 19 Oct 2026 | 12,000 | 239,303 | - | 11.4 | 136,645 | - |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 312.40 per share. | 19 Oct 2026 | 11,959 | 297,845 | - | 312.4 | 3,736,004 | - |
| Adaptive biotech Corp | Ms. Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 19 Oct 2026 | 11,881 | 389,683 (0%) | 0% | 12.1 | 144,235 | - |
| Adaptive biotech Corp | Ms. Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 24.05 per share. | 19 Oct 2026 | 11,881 | 377,802 (0%) | 0% | 24.0 | 285,738 | - |
| Adaptive biotech Corp | Ms. Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 19 Oct 2026 | 11,881 | 389,683 (0%) | 0% | 12.1 | 144,235 | - |
| Adaptive biotech Corp | Ms. Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 19 Oct 2026 | 11,881 | 389,683 (0%) | 0% | 12.1 | 144,235 | - |
| Adaptive biotech Corp | Ms. Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 24.53 per share. | 19 Oct 2026 | 11,781 | 377,902 (0%) | 0% | 24.5 | 288,988 | - |
| Disc Medicine Inc | Dr. Kevin Bitterman, PhD | Director | Sale of securities on an exchange or to another person at price $ 80.23 per share. | 19 Oct 2026 | 11,470 | 293,430 | - | 80.2 | 920,238 | - |
| Coty Inc (Class A) | Ms. Ayesha Zafar | SVP Group Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Oct 2026 | 9,745 | 191,560 (0%) | 0% | - | - | |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 19 Oct 2026 | 9,500 | 333,943 (0%) | 0% | 117.8 | 1,118,720 | - |
| Pagaya Tech Ltd (Class A) | Ms. Tami Rosen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.68 per share. | 19 Oct 2026 | 9,363 | 22,777 | - | 10.7 | 99,997 | - |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 311.06 per share. | 19 Oct 2026 | 9,220 | 309,804 | - | 311.1 | 2,867,973 | - |
| Oil-Dri Corp Of America | Ms. Christiansen Aaron | Vice President of Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.49 per share. | 19 Oct 2026 | 8,811 | 51,189 (0%) | 0% | 70.5 | 621,087 | - |
| Coty Inc (Class A) | Ms. Kristin Blazewicz | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2026 | 8,649 | 1,022,931 (0%) | 0% | - | - | |
| Castle Biosciences Inc | Mr. Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 31.91 per share. | 19 Oct 2026 | 8,580 | 12,484 (0%) | 0% | 31.9 | 273,788 | - |
| Adeia Inc | Mr. Kevin Tanji | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.05 per share. | 19 Oct 2026 | 8,133 | 305,409 (0%) | 0% | 21.1 | 171,200 | - |
| Adeia Inc | Dr. Mark Kokes, PhD | Chief Licensing Officer, Media | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.05 per share. | 19 Oct 2026 | 8,133 | 330,803 (0%) | 0% | 21.1 | 171,200 | - |
| MediaAlpha Inc (Class A) | Mr. Eugene Nonko | Director | Sale of securities on an exchange or to another person at price $ 11.39 per share. | 19 Oct 2026 | 7,273 | 827,276 | - | 11.4 | 82,826 | - |
| MediaAlpha Inc (Class A) | Mr. Eugene Nonko | Director | Sale of securities on an exchange or to another person at price $ 11.72 per share. | 19 Oct 2026 | 7,273 | 820,003 | - | 11.7 | 85,267 | - |
| MediaAlpha Inc (Class A) | Mr. Eugene Nonko | Director | Sale of securities on an exchange or to another person at price $ 11.63 per share. | 19 Oct 2026 | 7,273 | 812,730 | - | 11.6 | 84,565 | - |
| Rocky Mountain Chocolate Factory Inc | Mr. Brian J. Quinn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 7,000 | 112,961 (1%) | 0% | 0 | - | |
| Rocky Mountain Chocolate Factory Inc | Mr. Alberto Perez Jacome Friscione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 7,000 | 93,016 (1%) | 0% | 0 | - | |
| Worthington Steel Inc | Mr. Clifford J. Larivey | President Flat Rolled Stl Proc | Sale of securities on an exchange or to another person at price $ 40.14 per share. | 19 Oct 2026 | 6,868 | 26,651 | - | 40.1 | 275,698 | - |
| PACS Grp Inc | Mr. Jason Murray | Director, Co-Founder, CEO & Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.62 per share. | 19 Oct 2026 | 6,610 | 54,270,813 | - | 47.6 | 314,755 | - |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 319.99 per share. | 19 Oct 2026 | 6,310 | 19,024 | - | 320.0 | 2,019,168 | - |
| Insmed Inc | Mr. Paul Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2026 | 6,139 | 6,139 (0%) | 0% | - | - | |
| Coty Inc (Class A) | Ms. Anna von Bayern | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2026 | 6,105 | 1,609,947 (0%) | 0% | - | - | |
| Enliven Therapeutics Inc | Mr. Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.85 per share. | 19 Oct 2026 | 6,018 | 44,018 | - | 14.8 | 89,367 | - |
| Enliven Therapeutics Inc | Mr. Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.48 per share. | 19 Oct 2026 | 6,018 | 38,000 | - | 38.5 | 231,546 | - |
| Adaptive biotech Corp | Ms. Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 25.25 per share. | 19 Oct 2026 | 5,999 | 383,684 (0%) | 0% | 25.3 | 151,475 | - |
| Disc Medicine Inc | Dr. Kevin Bitterman, PhD | Director | Sale of securities on an exchange or to another person at price $ 79.97 per share. | 19 Oct 2026 | 5,937 | 312,929 | - | 80.0 | 474,782 | - |
| Adaptive biotech Corp | Ms. Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 25.57 per share. | 19 Oct 2026 | 5,882 | 377,802 (0%) | 0% | 25.6 | 150,403 | - |
| Paylocity Holding Corp | Mr. Steven I. Sarowitz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 166.47 per share. | 19 Oct 2026 | 5,875 | 4,414,756 (8%) | 0% | 166.5 | 978,011 | - |
| Finance of America Companies Inc | Mr. Jeremy Prahm | Chief Investment Officer | Sale of securities on an exchange or to another person at price $ 10.74 per share. | 19 Oct 2026 | 5,610 | 150,246 | - | 10.7 | 60,265 | - |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 19 Oct 2026 | 5,266 | 847,009 | - | 5.3 | 28,173 | - |
| Enliven Therapeutics Inc | Dr. Helen Collins, M.D. | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 19 Oct 2026 | 5,000 | 30,000 | - | 2.5 | 12,400 | - |
| Enliven Therapeutics Inc | Dr. Helen Collins, M.D. | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.47 per share. | 19 Oct 2026 | 5,000 | 25,000 | - | 38.5 | 192,342 | - |
| J.Jill Inc | Mr. Mark W. Webb | EVP, CFO & COO | Sale of securities on an exchange or to another person at price $ 24.52 per share. | 19 Oct 2026 | 5,000 | 113,523 (0%) | 0% | 24.5 | 122,600 | - |
| Disc Medicine Inc | Dr. Kevin Bitterman, PhD | Director | Sale of securities on an exchange or to another person at price $ 79.97 per share. | 19 Oct 2026 | 4,942 | 307,288 | - | 80.0 | 395,212 | - |
| Dolphin Entertainment Inc | Mr. William O’Dowd, IV | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 19 Oct 2026 | 4,700 | 578,542 (3%) | 0% | 1.0 | 4,916 | - |
| Paylocity Holding Corp | Mr. Steven I. Sarowitz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.99 per share. | 19 Oct 2026 | 4,570 | 4,420,631 (8%) | 0% | 166.0 | 758,574 | - |
| Coty Inc (Class A) | Ms. Anna von Bayern | Chief Corp. Affairs Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Oct 2026 | 4,457 | 1,603,842 (0%) | 0% | - | - | |
| Snowflake Inc (Class A) | Mr. Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 312.86 per share. | 19 Oct 2026 | 4,250 | 293,595 | - | 312.9 | 1,329,638 | - |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | 19 Oct 2026 | 4,172 | 4,172 | - | 0 | - | ||
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | 19 Oct 2026 | 4,172 | 4,172 | - | 0 | - | ||
| Coty Inc (Class A) | Ms. Kristin Blazewicz | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Oct 2026 | 4,143 | 1,018,788 (0%) | 0% | - | - | |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | 19 Oct 2026 | 4,135 | 4,135 | - | 0 | - | ||
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | 19 Oct 2026 | 4,135 | 4,135 | - | 0 | - | ||
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.29 per share. | 19 Oct 2026 | 4,081 | 54 | - | 47.3 | 192,976 | - |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.29 per share. | 19 Oct 2026 | 4,081 | 54 | - | 47.3 | 192,976 | - |
| Clover Health Investments Corp (Class A) | Ms. Jamie L. Reynoso | CEO, Medicare Advantage | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 19 Oct 2026 | 4,066 | 2,770,351 | - | 4.4 | 17,931 | - |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.84 per share. | 19 Oct 2026 | 4,003 | 169 | - | 47.8 | 191,513 | - |
| Ibotta Inc (Class A) | Mr. Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.84 per share. | 19 Oct 2026 | 4,003 | 169 | - | 47.8 | 191,513 | - |
| Crowdstrike (Class A) | Mr. George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 228.60 per share. | 19 Oct 2026 | 3,960 | 7,435,904 (18%) | 0% | 228.6 | 905,256 | - |
| Heron Therapeutics Inc | Ms. Ira Duarte | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2026 | 3,874 | 285,773 (0%) | 0% | - | - | |
| Heron Therapeutics Inc | Dr. William P. Forbes, Pharm.D. | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2026 | 3,874 | 245,047 (0%) | 0% | - | - | |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 19 Oct 2026 | 3,500 | 5,945 (0%) | 0% | 18 | 63,000 | - |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | 19 Oct 2026 | 3,500 | 2,445 (0%) | 0% | 0 | - | ||
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | 19 Oct 2026 | 3,500 | 109,327 (1%) | 0% | 0 | - | ||
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.00 per share. | 19 Oct 2026 | 3,500 | 5,945 (0%) | 0% | 24 | 84,000 | - |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.